Jakob Wested

Centre for Advanced Studies in Biomedical Innovation Law (CeBIL)

Post doc

Karen Blixens Plads 16

København S, 2300

Denmark

University of Copenhagen

Research Fellow, Phd, LL.M, Ba of arts

Karen Blixens Plads 16

København S, 2300

Denmark

Danish Medicines Agency

Axel Heides Gade 1

Copenhagen S, 2300

Denmark

SCHOLARLY PAPERS

13

DOWNLOADS
Rank 33,534

SSRN RANKINGS

Top 33,534

in Total Papers Downloads

2,845

SSRN CITATIONS

4

CROSSREF CITATIONS

1

Scholarly Papers (13)

1.

Research and Bolar Exemptions in the U.S. and Europe: Recent Developments and Possible Scenarios

Number of pages: 11 Posted: 30 Aug 2018
Jakob Wested and Timo Minssen
Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 1,015 (42,286)

Abstract:

Loading...

LIfe Science, Bolar Provision, Research Exemption, Patent, TRIPS Agreement

2.

The Role of Patents and Licensing in the Governance of Human Genome Editing: A White Paper

Queen Mary Law Research Paper No. 364/2021
Number of pages: 52 Posted: 02 Aug 2021 Last Revised: 12 Aug 2021
Queen Mary University of London - School of Law, School of Law, University of Aberdeen, affiliation not provided to SSRN, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, Faculty of Law, Lund University, Sweden, University of Illinois College of Law, Centre for Advanced Studies in Biomedical Innovation Law (CeBIL), Centre of Excellence GOVTRUST, University of Antwerp, Belgium and Maynooth University
Downloads 636 (79,020)

Abstract:

Loading...

3.

'No-One Is Safe until Everyone Is Safe' – Patent Waiver, Compulsory Licensing and COVID-19

Kianzad, B. , & Wested, J. ‘No-one is Safe Until Everyone is Safe’ – Patent Waiver, Compulsory Licensing and COVID-19 European Pharmaceutical Law Review Volume 5, Issue 2 (2021) pp. 71 - 91 DOI: https://doi.org/10.21552/eplr/2021/2/4
Number of pages: 21 Posted: 01 Jul 2021 Last Revised: 27 Jul 2021
Behrang Kianzad and Jakob Wested
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) and Centre for Advanced Studies in Biomedical Innovation Law (CeBIL)
Downloads 452 (120,122)

Abstract:

Loading...

COVID-19, compulsory licensing, patent waiver, TRIPS, WTO, vaccines, right-to-health, intellectual property rights, patents on medicine, competition law

4.

Standardization, IPRs and Open Innovation in Synthetic Biology

Timo Minssen, and Jakob B. Wested. “Standardization, IPRs and Open Innovation in Synthetic Biology.” Innovation, Competition and Collaboration. Edward Elgar Publishing, 2015. 34–66. Web.
Number of pages: 20 Posted: 16 Feb 2014 Last Revised: 21 Jul 2020
Timo Minssen and Jakob Wested
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Centre for Advanced Studies in Biomedical Innovation Law (CeBIL)
Downloads 287 (198,088)
Citation 4

Abstract:

Loading...

standardization, open innovation, synthetic biology, intellectual property rights

5.

TRIPS and the Life Sciences - Perspectives on Limitations to Patentability

University of Copenhagen Faculty of Law Research Paper No. 2017-37
Number of pages: 9 Posted: 16 Jun 2017 Last Revised: 08 Jul 2017
Jakob Wested and Timo Minssen
Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 128 (408,827)

Abstract:

Loading...

TRIPS agreement, Patents, Correa guidelines, Technological neutrality, non-discrimination, Life science, Pharmaindustry, Biotechnology

6.

Repositioning for Rare Diseases – Too Much, Too Little or Just Right?

NIR: Nordiskt Immateriellt Rättsskydd / Nordic Intellectual Property Law Review
Number of pages: 20 Posted: 23 Sep 2021
Jakob Wested and John Liddicoat
Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) and King’s College London
Downloads 99 (492,913)

Abstract:

Loading...

Orphan Drugs, Repurposing, Repositioning, IPR, Regulatory exclusivities, competition law

7.

An Update on Research- & Bolar Exemptions in the U.S. and Europe: Unsolved Questions and New Developments in an Increasingly Important Area of Law

NIR: Nordiskt Immateriellt Rättsskydd, Vol. 2019, No. 2, pp. 168-183
Number of pages: 12 Posted: 25 Apr 2019 Last Revised: 16 Jul 2020
Jakob Wested and Timo Minssen
Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 89 (527,741)

Abstract:

Loading...

8.

Procedural Aspects of Compulsory Licensing Under TRIPS: Report No. II of Webinar Series on Reinterpreting TRIPS in the Life Sciences

Number of pages: 9 Posted: 28 Sep 2017
Jakob Wested and Timo Minssen
Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 79 (567,142)

Abstract:

Loading...

TRIPS, Life Science, Patents, Compulsory Licensing, Access to Medicine, NATCO

9.

Has the EU Incentive for Drug Repositioning Been Effective? An Empirical Analysis of the '+1' Regulatory Exclusivity

52(7) International Review of Intellectual Property and Competition Law 825
Number of pages: 27 Posted: 31 Aug 2021
King’s College London, University of Cambridge - Faculty of Law, LML, University of Cambridge and Centre for Advanced Studies in Biomedical Innovation Law (CeBIL)
Downloads 60 (656,891)
Citation 1

Abstract:

Loading...

drug repositioning, regulatory exclusivities, patents, empirical study, intellectual property

10.

Innovation and Intellectual Property Policies in European Research Infrastructure Consortia — Part I: The Case of the European Spallation Source ERIC

Journal of Intellectual Property Law & Practice, Vol. 12, No. 5, 27.03.2017, p. 384–397. https://doi.org/10.1093/jiplp/jpx022
Posted: 17 Oct 2020
Helen Yu, Jakob Wested and Timo Minssen
University of Copenhagen - Center for Information and Innovation Law (CIIR), Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Abstract:

Loading...

11.

Will the EPO’s Enlarged Board of Appeal Hear the Broad's CRISPR Case?

In: Life Sciences Intellectual Property Review (LSIPR), No. 13/7 2018, 13.07.2018. https://www.lifesciencesipreview.com/article/will-the-epo-s-enlarged-board-hear-the-broad-s-crispr-case
Posted: 04 Sep 2020 Last Revised: 08 Sep 2020
Jakob Wested, Timo Minssen and Esther van Zimmeren
Centre for Advanced Studies in Biomedical Innovation Law (CeBIL), University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Centre of Excellence GOVTRUST, University of Antwerp, Belgium

Abstract:

Loading...

12.

Will the EPO’s Enlarged Board Hear the Broad’s CRISPR Case?

Life Sciences Intellectual Property Review (LSIPR), No. 13/7 2018, 13.07.2018.
Posted: 24 Apr 2019
Jakob Wested, Timo Minssen and Esther van Zimmeren
Centre for Advanced Studies in Biomedical Innovation Law (CeBIL), University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Centre of Excellence GOVTRUST, University of Antwerp, Belgium

Abstract:

Loading...

13.

Clearing a Way Through the CRISPR Patent Jungle

Life Sciences Intellectual Property Review (LSIPR), No. 8/5 2018, 2018.
Posted: 24 Apr 2019
Timo Minssen, Esther van Zimmeren and Jakob Wested
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, Centre of Excellence GOVTRUST, University of Antwerp, Belgium and Centre for Advanced Studies in Biomedical Innovation Law (CeBIL)

Abstract:

Loading...